{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:25:56Z","timestamp":1772119556645,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"DOI":"10.1007\/s10689-025-00526-z","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T07:48:22Z","timestamp":1767685702000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond 1100delC: distinct CHEK2 variants and unique cancer phenotypes in Northeast Brazil"],"prefix":"10.1007","volume":"25","author":[{"given":"Mariana Macambira","family":"Noronha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Robson Costa","family":"Passos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valbert Oliveira Costa","family":"Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thais Baccili Cury","family":"Megid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Teresa","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle Calheiros Campelo","family":"Maia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"issue":"6830","key":"526_CR1","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/35071124","volume":"410","author":"J Falck","year":"2001","unstructured":"Falck J, Mailand N, Sylju\u00e5sen RG, Bartek J, Lukas J (2001) The ATM\u2013Chk2\u2013Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410(6830):842\u2013847. https:\/\/doi.org\/10.1038\/35071124","journal-title":"Nature"},{"issue":"9","key":"526_CR2","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.trecan.2022.04.009","volume":"8","author":"RACM Boonen","year":"2022","unstructured":"Boonen RACM, Vreeswijk MPG, Van Attikum H (2022) CHEK2 variants: linking functional impact to cancer risk. Trends Cancer 8(9):759\u2013770. https:\/\/doi.org\/10.1016\/j.trecan.2022.04.009","journal-title":"Trends Cancer"},{"issue":"1","key":"526_CR3","doi-asserted-by":"publisher","first-page":"14763","DOI":"10.1038\/s41598-021-93926-x","volume":"11","author":"C Wendt","year":"2021","unstructured":"Wendt C, Muranen TA, Mielik\u00e4inen L et al (2021) A search for modifying genetic factors in CHEK2:c.1100delC breast cancer patients. Sci Rep 11(1):14763. https:\/\/doi.org\/10.1038\/s41598-021-93926-x","journal-title":"Sci Rep"},{"issue":"1","key":"526_CR4","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1038\/s41598-022-07383-1","volume":"12","author":"RSC Guindalini","year":"2022","unstructured":"Guindalini RSC, Viana DV, Kitajima JPFW et al (2022) Detection of germline variants in Brazilian breast cancer patients using multigene panel testing. Sci Rep 12(1):4190. https:\/\/doi.org\/10.1038\/s41598-022-07383-1","journal-title":"Sci Rep"},{"issue":"11","key":"526_CR5","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1001\/jamaoncol.2022.4071","volume":"8","author":"BL Bychkovsky","year":"2022","unstructured":"Bychkovsky BL, Agaoglu NB, Horton C et al (2022) Differences in cancer phenotypes among frequent CHEK2 variants and implications for clinical care\u2014checking CHEK2. JAMA Oncol 8(11):1598. https:\/\/doi.org\/10.1001\/jamaoncol.2022.4071","journal-title":"JAMA Oncol"},{"issue":"10","key":"526_CR6","doi-asserted-by":"publisher","first-page":"100870","DOI":"10.1016\/j.gim.2023.100870","volume":"25","author":"H Hanson","year":"2023","unstructured":"Hanson H, Astiazaran-Symonds E, Amendola LM et al (2023) Management of individuals with germline pathogenic\/likely pathogenic variants in CHEK2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med 25(10):100870. https:\/\/doi.org\/10.1016\/j.gim.2023.100870","journal-title":"Genet Med"},{"issue":"5","key":"526_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology Genet Med 17(5):405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"issue":"6","key":"526_CR8","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1086\/426403","volume":"75","author":"C Cybulski","year":"2004","unstructured":"Cybulski C, G\u00f3rski B, Huzarski T et al (2004) CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet 75(6):1131\u20131135. https:\/\/doi.org\/10.1086\/426403","journal-title":"Am J Hum Genet"},{"issue":"1","key":"526_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1200\/JCO.2005.05.5160","volume":"25","author":"M Weischer","year":"2007","unstructured":"Weischer M, Bojesen SE, Tybj\u00e6rg-Hansen A, Axelsson CK, Nordestgaard BG (2007) Increased risk of breast cancer associated with CHEK2 * 1100delC. J Clin Oncol 25(1):57\u201363. https:\/\/doi.org\/10.1200\/JCO.2005.05.5160","journal-title":"J Clin Oncol"},{"key":"526_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cancergen.2020.07.001","volume":"246\u2013247","author":"EG Sutcliffe","year":"2020","unstructured":"Sutcliffe EG, Stettner AR, Miller SA et al (2020) Differences in cancer prevalence among CHEK2 carriers identified via multi-gene panel testing. Cancer Genet 246\u2013247:12\u201317. https:\/\/doi.org\/10.1016\/j.cancergen.2020.07.001","journal-title":"Cancer Genet"},{"issue":"16suppl","key":"526_CR11","doi-asserted-by":"publisher","first-page":"e22539","DOI":"10.1200\/JCO.2023.41.16_suppl.e22539","volume":"41","author":"TA Santana","year":"2023","unstructured":"Santana TA, De Bustamante Fernandes C, Silva ACBN et al (2023) Frequency and spectrum of CHEK2 variants in a large Brazilian set of germline-tested patients. J Clin Oncol 41(16suppl):e22539\u2013e22539. https:\/\/doi.org\/10.1200\/JCO.2023.41.16_suppl.e22539","journal-title":"J Clin Oncol"},{"issue":"1","key":"526_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10549-023-07176-8","volume":"204","author":"CJ Schwartz","year":"2024","unstructured":"Schwartz CJ, Khorsandi N, Blanco A, Mukhtar RA, Chen YY, Krings G (2024) Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants. Breast Cancer Res Treat 204(1):171\u2013179. https:\/\/doi.org\/10.1007\/s10549-023-07176-8","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"526_CR13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10549-016-4085-4","volume":"161","author":"M Pritzlaff","year":"2017","unstructured":"Pritzlaff M, Summerour P, McFarland R et al (2017) Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results. Breast Cancer Res Treat 161(3):575\u2013586. https:\/\/doi.org\/10.1007\/s10549-016-4085-4","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"526_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ng879","volume":"31","author":"The CHEK2-Breast Cancer Consortium","year":"2002","unstructured":"The CHEK2-Breast Cancer Consortium (2002) Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31(1):55\u201359. https:\/\/doi.org\/10.1038\/ng879","journal-title":"Nat Genet"},{"issue":"8","key":"526_CR15","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/pros.23505","volume":"78","author":"Y Wu","year":"2018","unstructured":"Wu Y, Yu H, Zheng SL et al (2018) A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer. Prostate 78(8):607\u2013615. https:\/\/doi.org\/10.1002\/pros.23505","journal-title":"Prostate"},{"issue":"15suppl","key":"526_CR16","doi-asserted-by":"publisher","first-page":"5084","DOI":"10.1200\/JCO.2021.39.15_suppl.5084","volume":"39","author":"E Nizialek","year":"2021","unstructured":"Nizialek E, Lotan TL, Isaacs WB, Yegnasubramanian S, Paller CJ, Antonarakis ES (2021) The somatic mutation landscape of germline CHEK2- altered prostate cancer. J Clin Oncol 39(15suppl):5084\u20135084. https:\/\/doi.org\/10.1200\/JCO.2021.39.15_suppl.5084","journal-title":"J Clin Oncol"},{"issue":"4","key":"526_CR17","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/jamaoncol.2018.6477","volume":"5","author":"SH AlDubayan","year":"2019","unstructured":"AlDubayan SH, Pyle LC, Gamulin M et al (2019) Association of inherited pathogenic variants in checkpoint kinase 2 (CHEK2) with susceptibility to testicular germ cell tumors. JAMA Oncol 5(4):514. https:\/\/doi.org\/10.1001\/jamaoncol.2018.6477","journal-title":"JAMA Oncol"},{"issue":"4","key":"526_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11899-022-00663-7","volume":"17","author":"RJ Stubbins","year":"2022","unstructured":"Stubbins RJ, Korotev S, Godley LA (2022) Germline CHEK2 and ATM variants in myeloid and other hematopoietic malignancies. Curr Hematol Malig Rep 17(4):94\u2013104. https:\/\/doi.org\/10.1007\/s11899-022-00663-7","journal-title":"Curr Hematol Malig Rep"},{"issue":"12","key":"526_CR19","doi-asserted-by":"publisher","first-page":"a026195","DOI":"10.1101\/cshperspect.a026195","volume":"6","author":"MI Achatz","year":"2016","unstructured":"Achatz MI, Zambetti GP (2016) The inherited p53 mutation in the Brazilian population. Cold Spring Harb Perspect Med 6(12):a026195. https:\/\/doi.org\/10.1101\/cshperspect.a026195","journal-title":"Cold Spring Harb Perspect Med"},{"key":"526_CR20","doi-asserted-by":"publisher","first-page":"932957","DOI":"10.3389\/fonc.2022.932957","volume":"12","author":"ACLVC Gifoni","year":"2022","unstructured":"Gifoni ACLVC, Gifoni MAC, Wotroba CM et al (2022) Hereditary breast cancer in the Brazilian state of Cear\u00e1 (The CHANCE Cohort): higher-than-expected prevalence of recurrent germline pathogenic variants. Front Oncol 12:932957. https:\/\/doi.org\/10.3389\/fonc.2022.932957","journal-title":"Front Oncol"},{"key":"526_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.breast.2022.06.003","volume":"65","author":"R Graffeo","year":"2022","unstructured":"Graffeo R, Rana HQ, Conforti F et al (2022) Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D. Breast 65:32\u201340. https:\/\/doi.org\/10.1016\/j.breast.2022.06.003","journal-title":"Breast"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00526-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-025-00526-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00526-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T07:48:30Z","timestamp":1767685710000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-025-00526-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["526"],"URL":"https:\/\/doi.org\/10.1007\/s10689-025-00526-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7653623\/v1","asserted-by":"object"}]},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"19 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This project was approved by the Research Ethics Committee of the Universidade Federal do Cear\u00e1, Brazil, and all individuals provided written consent for multi-gene testing (protocol number CAAE 73014023.7.0000.5054).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"8"}}